Clinical trials: Nonfluent Aphasia
Nonfluent Aphasia, Stroke
Augmenting Language Therapy for Aphasia: Levodopa
The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e.
- Trial name
- NCT01429077
- Testing
- levodopa/carbidopa
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- Shirley Ryan AbilityLab